Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture

Petra Neddermann, Manuela Quintavalle, Chiara Di Pietro, Angelica Clementi, Mauro Cerretani, Sergio Altamura, Linda Bartholomew, Raffaele De Francesco

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Efficient replication of hepatitis C virus (HCV) subgenomic RNA in cell culture requires the introduction of adaptive mutations. In this report we describe a system which enables efficient replication of the Con1 subgenomic replicon in Huh7 cells without the introduction of adaptive mutations. The starting hypothesis was that high amounts of the NS5A hyperphosphorylated form, p58, inhibit replication and that reduction of p58 by inhibition of specific kinase(s) below a certain threshold enables HCV replication. Upon screening of a panel of kinase inhibitors, we selected three compounds which inhibited NS5A phosphorylation in vitro and the formation of NS5A p58 in cell culture. Cells, transfected with the HCV Con1 wild-type sequence, support HCV RNA replication upon addition of any of the three compounds. The effect of the kinase inhibitors was found to be synergistic with coadaptive mutations in NS3. This is the first direct demonstration that the presence of high amounts of NS5A-p58 causes inhibition of HCV RNA replication in cell culture and that this inhibition can be relieved by kinase inhibitors.

Original languageEnglish
Pages (from-to)13306-13314
Number of pages9
JournalJournal of Virology
Volume78
Issue number23
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Hepatitis C virus
Viral RNA
Hepacivirus
phosphotransferases (kinases)
cell culture
Phosphotransferases
Cell Culture Techniques
Virus Replication
RNA
mutation
Mutation
replicon
Replicon
virus replication
phosphorylation
Phosphorylation
RNA replication
cells
screening

ASJC Scopus subject areas

  • Immunology

Cite this

Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture. / Neddermann, Petra; Quintavalle, Manuela; Di Pietro, Chiara; Clementi, Angelica; Cerretani, Mauro; Altamura, Sergio; Bartholomew, Linda; De Francesco, Raffaele.

In: Journal of Virology, Vol. 78, No. 23, 12.2004, p. 13306-13314.

Research output: Contribution to journalArticle

Neddermann, Petra ; Quintavalle, Manuela ; Di Pietro, Chiara ; Clementi, Angelica ; Cerretani, Mauro ; Altamura, Sergio ; Bartholomew, Linda ; De Francesco, Raffaele. / Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture. In: Journal of Virology. 2004 ; Vol. 78, No. 23. pp. 13306-13314.
@article{05961feafe7f4178b39a84fabf4e6e91,
title = "Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture",
abstract = "Efficient replication of hepatitis C virus (HCV) subgenomic RNA in cell culture requires the introduction of adaptive mutations. In this report we describe a system which enables efficient replication of the Con1 subgenomic replicon in Huh7 cells without the introduction of adaptive mutations. The starting hypothesis was that high amounts of the NS5A hyperphosphorylated form, p58, inhibit replication and that reduction of p58 by inhibition of specific kinase(s) below a certain threshold enables HCV replication. Upon screening of a panel of kinase inhibitors, we selected three compounds which inhibited NS5A phosphorylation in vitro and the formation of NS5A p58 in cell culture. Cells, transfected with the HCV Con1 wild-type sequence, support HCV RNA replication upon addition of any of the three compounds. The effect of the kinase inhibitors was found to be synergistic with coadaptive mutations in NS3. This is the first direct demonstration that the presence of high amounts of NS5A-p58 causes inhibition of HCV RNA replication in cell culture and that this inhibition can be relieved by kinase inhibitors.",
author = "Petra Neddermann and Manuela Quintavalle and {Di Pietro}, Chiara and Angelica Clementi and Mauro Cerretani and Sergio Altamura and Linda Bartholomew and {De Francesco}, Raffaele",
year = "2004",
month = "12",
doi = "10.1128/JVI.78.23.13306-13314.2004",
language = "English",
volume = "78",
pages = "13306--13314",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "23",

}

TY - JOUR

T1 - Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture

AU - Neddermann, Petra

AU - Quintavalle, Manuela

AU - Di Pietro, Chiara

AU - Clementi, Angelica

AU - Cerretani, Mauro

AU - Altamura, Sergio

AU - Bartholomew, Linda

AU - De Francesco, Raffaele

PY - 2004/12

Y1 - 2004/12

N2 - Efficient replication of hepatitis C virus (HCV) subgenomic RNA in cell culture requires the introduction of adaptive mutations. In this report we describe a system which enables efficient replication of the Con1 subgenomic replicon in Huh7 cells without the introduction of adaptive mutations. The starting hypothesis was that high amounts of the NS5A hyperphosphorylated form, p58, inhibit replication and that reduction of p58 by inhibition of specific kinase(s) below a certain threshold enables HCV replication. Upon screening of a panel of kinase inhibitors, we selected three compounds which inhibited NS5A phosphorylation in vitro and the formation of NS5A p58 in cell culture. Cells, transfected with the HCV Con1 wild-type sequence, support HCV RNA replication upon addition of any of the three compounds. The effect of the kinase inhibitors was found to be synergistic with coadaptive mutations in NS3. This is the first direct demonstration that the presence of high amounts of NS5A-p58 causes inhibition of HCV RNA replication in cell culture and that this inhibition can be relieved by kinase inhibitors.

AB - Efficient replication of hepatitis C virus (HCV) subgenomic RNA in cell culture requires the introduction of adaptive mutations. In this report we describe a system which enables efficient replication of the Con1 subgenomic replicon in Huh7 cells without the introduction of adaptive mutations. The starting hypothesis was that high amounts of the NS5A hyperphosphorylated form, p58, inhibit replication and that reduction of p58 by inhibition of specific kinase(s) below a certain threshold enables HCV replication. Upon screening of a panel of kinase inhibitors, we selected three compounds which inhibited NS5A phosphorylation in vitro and the formation of NS5A p58 in cell culture. Cells, transfected with the HCV Con1 wild-type sequence, support HCV RNA replication upon addition of any of the three compounds. The effect of the kinase inhibitors was found to be synergistic with coadaptive mutations in NS3. This is the first direct demonstration that the presence of high amounts of NS5A-p58 causes inhibition of HCV RNA replication in cell culture and that this inhibition can be relieved by kinase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=8644290077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8644290077&partnerID=8YFLogxK

U2 - 10.1128/JVI.78.23.13306-13314.2004

DO - 10.1128/JVI.78.23.13306-13314.2004

M3 - Article

C2 - 15542681

AN - SCOPUS:8644290077

VL - 78

SP - 13306

EP - 13314

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 23

ER -